Literature DB >> 17403002

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?

S Haag1, W Senf, S Tagay, M Langkafel, U Braun-Lang, A Pietsch, G Heuft, N J Talley, G Holtmann.   

Abstract

AIM: In a prospective randomized, controlled trial, to compare the long-term outcome of intensive medical therapy (with or without cognitive-behavioural or muscle relaxation therapy) vs. standard medical therapy in patients with refractory functional dyspepsia (FD), referred to a tertiary referral medical center.
METHODS: A total of 100 consecutive FD patients were allocated to a standardized symptom-oriented 4 month therapy (SMT, n = 24), intensive medical therapy (IMT, medical therapy with testing-for and targeting-of abnormalities of motor-and-sensory function, n = 28) or IMT plus psychological interventions (either progressive-muscle relaxation (IMT-MR, n = 20) or cognitive-behavioural therapy (IMT-CBT, n = 28). The symptom intensity (SI) and health-related quality-of-life (HRQoL) after 12 months were prespecified primary outcome parameters.
RESULTS: After 12 months, significantly greater improvement of SI occurred in patients with IMT-all (with or without psychological interventions) compared with SMT (P < 0.025 vs. IMT-all). IMT, IMT-MR and IMT-CBT alone also resulted in significantly better improvement of the primary outcome parameters (P all < 0.025 vs. SMT). HRQoL significantly improved in all groups with intensive medical therapy but not standard medical therapy. Differences between intensive medical therapy-all and standard medical therapy were not significant. Concomitant anxiety and depression was improved significantly by IMT-CBT (vs. SMT) but not other treatments.
CONCLUSIONS: In FD patients with refractory symptoms, intensified medical management involving function testing and psychological intervention yields superior long-term-outcomes. Additional CBT may be effective for the control of concomitant anxiety and depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403002     DOI: 10.1111/j.1365-2036.2007.03277.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

2.  Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China.

Authors:  Shu-Man Jiang; Lin Jia; Xiao-Gai Lei; Ming Xu; Sheng-Bing Wang; Jing Liu; Min Song; Wei-Dong Li
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

4.  Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management.

Authors:  Justin Cy Wu
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

5.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

6.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

Review 7.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

Review 8.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

9.  Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn?

Authors:  Sarah K Thompson; Wang Cai; Glyn G Jamieson; Alison Y Zhang; Jennifer C Myers; Zoe E Parr; David I Watson; Jenny Persson; Gerald Holtmann; Peter G Devitt
Journal:  J Gastrointest Surg       Date:  2008-08-20       Impact factor: 3.452

10.  Prevalence of Helicobacter Pylori Infection and Stress, Anxiety or Depression in Functional Dyspepsia and Outcome after Appropriate Intervention.

Authors:  Kirti Katherine Kabeer; Nilakanthan Ananthakrishnan; Chetan Anand; Sivaprakash Balasundaram
Journal:  J Clin Diagn Res       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.